Public Sector Pension Investment Board (PSP Investments)’s Tvardi Therapeutics TVRD Stock Holding History

Public Sector Pension Investment Board (PSP Investments)’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,205	Closed	-$390K	–	1417
2023 Q1	$390K	Sell	2,205 -93	-4%	-$31.1K	﹤0.01%	1380
2022 Q4	$888K	Hold	2,298	–	–	0.01%	1260
2022 Q3	$774K	Buy	2,298 +127	+6%	+$46K	0.01%	1237
2022 Q2	$714K	Hold	2,171	–	–	0.01%	1257
2022 Q1	$950K	Buy	+2,171	New	+$891K	0.01%	1284

Other funds holding TVRD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments)'s TVRD Position: Q2 2023 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of Tvardi Therapeutics (TVRD) in Q2 2023, closing a stake of 2,205 shares — an estimated $390K sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in TVRD in Q1 2022 and held it in 5 quarters. The position peaked at $950K in Q1 2022. 137 funds tracked by Wall St. Rank hold TVRD as of Q2 2023.

Public Sector Pension Investment Board (PSP Investments) reported no remaining Tvardi Therapeutics position as of Q2 2023 after selling out during the quarter.
Public Sector Pension Investment Board (PSP Investments) sold 2,205 Tvardi Therapeutics shares in Q2 2023, an estimated $390K.
Public Sector Pension Investment Board (PSP Investments) first reported a position in Tvardi Therapeutics in Q1 2022 and held it in 5 quarters.
Public Sector Pension Investment Board (PSP Investments)'s Tvardi Therapeutics position peaked at $950K in Q1 2022.
137 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2023.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q2 2023, filed 14 Aug 2023.